Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

被引：0
|
作者：
Becky A. S. Bibby
Niluja Thiruthaneeswaran
Lingjian Yang
Ronnie R. Pereira
Elisabet More
Darragh G. McArt
Paul O’Reilly
Robert G. Bristow
Kaye J. Williams
Ananya Choudhury
Catharine M. L. West
机构：
[1] University of Manchester,Translational Radiobiology Group, Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health
[2] Manchester Academic Health Sciences Centre,Sydney Medical School
[3] The Christie NHS Foundation Trust,Translational Oncogenomics
[4] University of Sydney,Centre for Cancer Research and Cell Biology
[5] CRUK Manchester Institute and CRUK Manchester Centre,School of Pharmacy and Pharmaceutical Sciences
[6] Queen’s University Belfast,undefined
[7] University of Manchester,undefined
来源：
BMC Urology | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] A review of FDA approved drugs and their formulations for the treatment of breast cancer
    Chaurasia, Mohini
    Singh, Romi
    Sur, Srija
    Flora, S. J. S.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [42] An update on nanoformulations with FDA approved drugs for female reproductive cancer
    Raj, Mahima
    Meena, Abha
    Seth, Richa
    Mathur, Anurag
    Luqman, Suaib
    JOURNAL OF MICROENCAPSULATION, 2025,
  • [43] Repurposing FDA-approved Ebselen and Auranofin as anti-fungal drugs: teaching old drugs new tricks
    Chaturvedi, A. K.
    Wall, G.
    Wormley, F. L., Jr.
    Lopez-Ribot, J. L.
    MEDICAL MYCOLOGY, 2018, 56 : S49 - S49
  • [44] Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
    Ku, Keun Bon
    Shin, Hye Jin
    Kim, Hae Soo
    Kim, Bum-Tae
    Kim, Seong-Jun
    Kim, Chonsaeng
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, 30 (12) : 1843 - 1853
  • [45] The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study
    Tovar-Nieto, Andrea Michel
    Flores-Padilla, Luis Enrique
    Rivas-Santiago, Bruno
    Trujillo-Paez, Juan Valentin
    Lara-Ramirez, Edgar Eduardo
    Jacobo-Delgado, Yolanda M.
    Lopez-Ramos, Juan Ernesto
    Rodriguez-Carlos, Adrian
    MICROORGANISMS, 2024, 12 (08)
  • [46] Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
    Dylan Jones
    Clarissa A. Whitehead
    Marija Dinevska
    Samuel S. Widodo
    Liam M. Furst
    Andrew P. Morokoff
    Andrew H. Kaye
    Katharine J. Drummond
    Theo Mantamadiotis
    Stanley S. Stylli
    Molecular and Cellular Biochemistry, 2023, 478 : 1251 - 1267
  • [47] Repurposing FDA-approved drugs to inhibit IL-33 mediated mast cell function
    Long, Dionna L.
    Burchett, Jason R.
    Ryan, John J.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [48] Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization
    Kulkarni, Ameya S.
    Aleksic, Sandra
    Berger, David M.
    Sierra, Felipe
    Kuchel, George A.
    Barzilai, Nir
    AGING CELL, 2022, 21 (04)
  • [49] Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs
    Kouznetsova, Valentina L.
    Huang, David Z.
    Tsigelny, Igor F.
    PHYSICAL BIOLOGY, 2021, 18 (02)
  • [50] Editorial note: repurposing FDA approved drugs as FXR agonists: a structure based in silico pharmacological study
    不详
    BIOSCIENCE REPORTS, 2022, 42 (08)
12345